Log In
BCIQ
Print this Print this
 

0.1% cyclosporine ophthalmic solution (ST-603)

  Manage Alerts
Collapse Summary General Information
Company Sirion Therapeutics Inc.
DescriptionTopical cyclosporine A formulated using Sophisen ophthalmic delivery system
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase III
Standard IndicationDry eye
Indication DetailsTreat dry eye syndrome
Regulatory Designation
PartnerLaboratorios Sophia S.A. de C.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/25/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today